시장보고서

상품코드

1679465

방광경 시장 규모, 점유율, 동향 분석 보고서 : 제품별, 최종 용도별, 유형별, 지역별, 부문 예측(2025-2030년)

Cystoscope Market Size, Share & Trends Analysis Report By Product (Flexible Cystoscopes, Rigid Cystoscopes), By Application (Urology, Gynecology), By End Use (Hospitals), By Type (Video Cystoscopes), By Region, And Segment Forecasts, 2025 - 2030

발행일: 2025년 02월 | 리서치사:

Grand View Research | 페이지 정보: 영문 100 Pages | 배송안내 : 2-10일 (영업일 기준)

샘플 요청 목록에 추가

※ 본 상품은 영문 자료로 한글과 영문 목차에 불일치하는 내용이 있을 경우 영문을 우선합니다. 정확한 검토를 위해 영문 목차를 참고해주시기 바랍니다.

방광경 시장 성장과 동향

Grand View Research, Inc.의 최신 보고서에 따르면 세계의 방광경 시장 규모는 2030년까지 21억 7,000만 달러에 이르고, 예측 기간 동안 CAGR 9.99%를 나타낼 것으로 예측됩니다. 방광경 시장은 기술 진보, 임상 검사 건수 증가, 산업 기업간 경쟁 격화 등 수많은 요인들에 의해 견인되고 있습니다.

광범위한 용도로 방광경을 사용하는 연구 활동과 임상 연구에 대한 관심 증가는 향후 수년간 시장 성장을 가속할 것으로 예측됩니다. 예를 들어 2024년 12월, Medtecx Co Ltd.는 전립선 비대증 치료에 대한 수증기 온열 요법 시스템의 안전성과 효능을 평가하기 위해 126명의 연구 참가자를 포함한 임상 검사를 후원했습니다.

게다가 2023년 2월 보도와 대학 병원은 연성 방광경을 사용하여 간헐적 방광 카테터를 사용하는 경우와 동질의 분석용 채뇨가 가능하며 환자의 불쾌감이 적음을 실증하는 임상 검사를 후원했습니다. 이 연구에는 약 414명이 참여했습니다. 따라서 다양한 임상 검사 및 연구에서 방광경의 이용 확대가 향후 수년간 시장 성장을 가속할 것으로 예상됩니다.

게다가 비뇨기과 질환의 유병률 증가로 방광경 검사에 대한 수요가 높아지고 있는 것도 시장 성장을 뒷받침할 것으로 예상됩니다. 상당수의 방광경 검사가 병원과 외래 모두에서 실시되었습니다. 예를 들어 2024년 7월에 발표된 MD Anderson Cancer Cente의 데이터에 따르면, 하루에 약 16건의 방광경 검사가 실시되고 있으며, 합계하면 연간 4,000건을 넘습니다. 이러한 대량의 진단 처치가 향후 수년간 방광경 시장의 성장을 자극할 것으로 예측되고 있습니다.

방광경 시장 보고서 하이라이트

연질 방광경 부문은 시장을 독점하며 예측 기간 동안 10.93%의 가장 빠른 CAGR을 나타낼 것으로 예측됩니다.
비디오 방광경 부문은 시장을 독점하고 예측 기간 동안 10.73%의 가장 빠른 CAGR을 나타낼 것으로 예상됩니다. 비디오 방광경과 같은 고급 방광경에 대한 규제 당국의 승인 증가는이 부문의 성장을 지원합니다.
비뇨기 부문은 시장을 독점하고 있으며 향후 몇 년 동안 10.56%의 가장 빠른 CAGR을 나타낼 것으로 예측됩니다. 요실금, 요로 감염, 방광암 등 비뇨기과 질환의 유병률 증가가 이 부문의 성장을 가속할 것으로 예측되고 있습니다.
병원 부문은 시장을 독점했으며 2024년에는 40.64%의 수익 점유율을 차지했습니다. 반면 외래수술센터(ASC) 부문은 향후 몇 년 동안 가장 높은 CAGR을 나타낼 것으로 예상됩니다.

부문 대시보드
세계의 방광경 시장 변동 분석
세계의 방광경 시장 규모와 동향 분석, 최종 용도별(2018-2030년)
병원
- 병원 시장 추정·예측(2018-2030년)
진단 이미징 센터
- 진단 이미징 센터 시장 추정·예측(2018-2030년)
외래수술센터(ASC)
- 외래수술센터(ASC) 시장 추정·예측(2018-2030년)
기타
- 기타 시장 추정·예측(2018-2030년)

제7장 방광경 시장 : 유형별, 추정·동향 분석

부문 대시보드
세계의 방광경 시장 변동 분석
세계의 방광경 시장 규모와 동향 분석, 유형별(2018-2030년)
비디오 방광경
광섬유 방광경

제8장 방광경 시장 : 지역별, 추정·동향 분석

지역 대시보드
시장 규모와 예측과 동향 분석(2018-2030년)
북미
- 시장 추정·예측(2018-2030년)
- 미국
- 캐나다
- 멕시코
유럽
- 영국
- 독일
- 프랑스
- 이탈리아
- 스페인
- 덴마크
- 스웨덴
- 노르웨이
아시아태평양
- 일본
- 인도
- 중국
- 한국
- 호주
- 태국
라틴아메리카
- 브라질
- 아르헨티나
중동 및 아프리카
- 남아프리카
- 사우디아라비아
- 아랍에미리트(UAE)
- 쿠웨이트

제9장 경쟁 구도

시장 진출기업의 분류
주요 기업 프로파일
- Olympus Corporation
- Boston Scientific Corporation 및 계열사
- Ambu Inc.
- KARL STORZ
- Advin Health Care
- Intuitive Surgical(SCHOLLY FIBEROPTIC GMBH)
- Stryker
- UroViu Corporation
- NeoScope Inc.
- OTU Medical
- HOYA Corporation(Pentax Medical)
히트맵 분석/기업시장 포지셔닝 분석
2024년 기업의 시장 점유율 추정 분석
기타 주요 시장 진출기업 일람

KTH 25.04.15

Cystoscope Market Growth & Trends:

The global cystoscope market size is anticipated to reach USD 2.17 billion by 2030 and is anticipated to expand at a CAGR of 9.99% during the forecast period, according to a new report by Grand View Research, Inc. The cystoscope market is driven by numerous factors such as technological advancements, rising number of clinical trials and growing competition among the industry players.

The increasing focus on research activities and clinical studies using cystoscopes in wide applications is anticipated to propel the market growth in the coming years. For instance, in December 2024, Medtecx Co Ltd. sponsored a clinical trial involving 126 study participants to evaluate the safety and efficacy of the water vapor thermal therapy system for treating benign prostatic hyperplasia.

Moreover, in February 2023, the Centre Hospitalier Universitaire Vaudois sponsored a clinical study to demonstrate that using a flexible cystoscope provides the same quality of urine collection for analysis as using an intermittent bladder catheter while being less uncomfortable for the patient. The study enrolled approximately 414 participants . Therefore, the growing utilization of cystoscopes in various clinical trials and studies is expected to drive market growth in the coming years.

Furthermore, the growing demand for cystoscopy procedures, driven by the increasing prevalence of urological disorders, is expected to boost market growth. A significant number of cystoscopy procedures are being conducted in both hospitals and outpatient settings. For instance, data from the MD Anderson Cancer Center published in July 2024 indicates that approximately 16 cystoscopies are performed daily, totaling over 4,000 annually. This high volume of diagnostic procedures is projected to stimulate cystoscope market growth in the coming years.

Cystoscope Market Report Highlights:

The flexible cystoscope segment dominated the market and is expected to register the fastest CAGR of 10.93% during the forecast period, owing to novel product launches by industry key players to expand their product portfolio.
The video cystoscope segment dominated the market and is expected to register the fastest CAGR of 10.73% during the forecast period. The increasing regulatory approvals for advanced cystoscopes, such as video cystoscopes, are supporting the segment's growth.
The urology segment dominated the market and is expected to register the fastest CAGR of 10.56% in the coming years. The increasing prevalence of urological conditions such as urinary incontinence, urinary tract infections, and bladder cancer is anticipated to drive the segment's growth.
The hospital segment dominated the market and accounted for the revenue share of 40.64% in 2024. On the other hand, the ambulatory surgery center segment is expected to grow with the highest CAGR in the coming years.

Chapter 1. Methodology and Scope

1.1. Market Segmentation and Scope
1.2. Research Methodology
1.3. Information Procurement
1.4. Information or Data Analysis
1.5. Market Formulation & Validation
1.6. Model Details
1.7. List of Data Sources

Chapter 2. Executive Summary

2.1. Market Outlook
2.2. Segment Outlook
2.3. Competitive Insights

Chapter 3. Cystoscope Market Variables, Trends & Scope

3.1. Market Lineage Outlook
- 3.1.1. Parent market outlook
3.2. Market Dynamics
- 3.2.1. Market driver analysis
  - 3.2.1.1. Increasing prevalence of urological & gynecological disorders
  - 3.2.1.2. Technological advancements
  - 3.2.1.3. Growing geriatric population
- 3.2.2. Market restraint analysis
  - 3.2.2.1. High cost of advanced cystoscope products and associated treatments
  - 3.2.2.2. Adverse effects and risk of complications associated with the use of cystoscopes
- 3.2.3. Market opportunity analysis
  - 3.2.3.1. Increasing focus on research & development
  - 3.2.3.2. Growth potential in emerging economies in cystoscope market
  - 3.2.3.3. Rising number of clinical trials
- 3.2.4. Market challenge analysis
  - 3.2.4.1. Growing number of product recalls
3.3. Cystoscope Market Analysis Tools
- 3.3.1. Industry Analysis - Porter's
  - 3.3.1.1. Bargaining power of suppliers
  - 3.3.1.2. Bargaining power of buyers
  - 3.3.1.3. Threat of substitutes
  - 3.3.1.4. Threat of new entrants
  - 3.3.1.5. Competitive rivalry
- 3.3.2. PESTEL Analysis
  - 3.3.2.1. Political & Legal Landscape
  - 3.3.2.2. Economic and Social Landscape
  - 3.3.2.3. Technological landscape

Chapter 4. Cystoscope Market: Product Estimates & Trend Analysis

4.1. Segment Dashboard
4.2. Global Cystoscope Market Movement Analysis
4.3. Global Cystoscope Market Size & Trend Analysis, by Product, 2018 to 2030 (USD Million)
4.4. Flexible Cystoscopes
- 4.4.1. Flexible cystoscopes market estimates and forecast 2018 to 2030 (USD Million)
4.5. Rigid cystoscope
- 4.5.1. Rigid cystoscope market estimates and forecast 2018 to 2030 (USD Million)

Chapter 5. Cystoscope Market: Application Estimates & Trend Analysis

5.1. Segment Dashboard
5.2. Global Cystoscope Market Movement Analysis
5.3. Global Cystoscope Market Size & Trend Analysis, by Application, 2018 to 2030 (USD Million)
5.4. Urology
- 5.4.1. Urology market estimates and forecast 2018 to 2030 (USD Million)
5.5. Gynecology
- 5.5.1. Gynecology market estimates and forecast 2018 to 2030 (USD Million)

Chapter 6. Cystoscope Devices: End Use Estimates & Trend Analysis

6.1. Segment Dashboard
6.2. Global Cystoscope Market Movement Analysis
6.3. Global Cystoscope Market Size & Trend Analysis, by End Use, 2018 to 2030 (USD Million)
6.4. Hospitals
- 6.4.1. Hospitals market estimates and forecast 2018 to 2030 (USD Million)
6.5. Diagnostic Imaging Centers
- 6.5.1. Diagnostic imaging centers market estimates and forecast 2018 to 2030 (USD Million)
6.6. Ambulatory Surgery Centers
- 6.6.1. Ambulatory surgery centers market estimates and forecast 2018 to 2030 (USD Million)
6.7. Others
- 6.7.1. Others market estimates and forecast 2018 to 2030 (USD Million)

Chapter 7. Cystoscope Market: Type Estimates & Trend Analysis

7.1. Segment Dashboard
7.2. Global Cystoscope Market Movement Analysis
7.3. Global Cystoscope Market Size & Trend Analysis, by Mode Of Purchase, 2018 to 2030 (USD Million)
7.4. Video Cystoscopes
- 7.4.1. Video cystoscopes market estimates and forecast 2018 to 2030 (USD Million)
7.5. Fiberoptic Cystoscopes
- 7.5.1. Fiberoptic cystoscopes market estimates and forecast 2018 to 2030 (USD Million)

Chapter 8. Cystoscope Market: Regional Estimates & Trend Analysis

8.1. Regional Dashboard
8.2. Market Size & Forecasts and Trend Analysis, 2018 to 2030
8.3. North America
- 8.3.1. Market estimates and forecast, 2018-2030 (Revenue, USD Million)
- 8.3.2. U.S.
  - 8.3.2.1. Key country dynamics
  - 8.3.2.2. Competitive scenario
  - 8.3.2.3. Regulatory framework
  - 8.3.2.4. Reimbursement scenario
  - 8.3.2.5. U.S. market estimates and forecasts, 2018-2030
- 8.3.3. Canada
  - 8.3.3.1. Key country dynamics
  - 8.3.3.2. Competitive scenario
  - 8.3.3.3. Regulatory framework
  - 8.3.3.4. Reimbursement scenario
  - 8.3.3.5. Canada market estimates and forecasts, 2018-2030
- 8.3.4. Mexico
  - 8.3.4.1. Key country dynamics
  - 8.3.4.2. Competitive scenario
  - 8.3.4.3. Regulatory framework
  - 8.3.4.4. Reimbursement scenario
  - 8.3.4.5. Mexico market estimates and forecasts, 2018-2030
8.4. Europe
- 8.4.1. UK
  - 8.4.1.1. Key country dynamics
  - 8.4.1.2. Competitive scenario
  - 8.4.1.3. Regulatory framework
  - 8.4.1.4. Reimbursement scenario
  - 8.4.1.5. UK market estimates and forecasts, 2018-2030
- 8.4.2. Germany
  - 8.4.2.1. Key country dynamics
  - 8.4.2.2. Competitive scenario
  - 8.4.2.3. Regulatory framework
  - 8.4.2.4. Reimbursement scenario
  - 8.4.2.5. Germany market estimates and forecasts, 2018-2030
- 8.4.3. France
  - 8.4.3.1. Key country dynamics
  - 8.4.3.2. Competitive scenario
  - 8.4.3.3. Regulatory framework
  - 8.4.3.4. Reimbursement scenario
  - 8.4.3.5. France market estimates and forecasts, 2018-2030
- 8.4.4. Italy
  - 8.4.4.1. Key country dynamics
  - 8.4.4.2. Competitive scenario
  - 8.4.4.3. Regulatory framework
  - 8.4.4.4. Reimbursement scenario
  - 8.4.4.5. Italy market estimates and forecasts, 2018-2030
- 8.4.5. Spain
  - 8.4.5.1. Key country dynamics
  - 8.4.5.2. Competitive scenario
  - 8.4.5.3. Regulatory framework
  - 8.4.5.4. Reimbursement scenario
  - 8.4.5.5. Spain market estimates and forecasts, 2018-2030
- 8.4.6. Denmark
  - 8.4.6.1. Key country dynamics
  - 8.4.6.2. Competitive scenario
  - 8.4.6.3. Regulatory framework
  - 8.4.6.4. Reimbursement scenario
  - 8.4.6.5. Denmark market estimates and forecasts, 2018-2030
- 8.4.7. Sweden
  - 8.4.7.1. Key country dynamics
  - 8.4.7.2. Competitive scenario
  - 8.4.7.3. Regulatory framework
  - 8.4.7.4. Reimbursement scenario
  - 8.4.7.5. Sweden market estimates and forecasts, 2018-2030
- 8.4.8. Norway
  - 8.4.8.1. Key country dynamics
  - 8.4.8.2. Competitive scenario
  - 8.4.8.3. Regulatory framework
  - 8.4.8.4. Reimbursement scenario
  - 8.4.8.5. Norway market estimates and forecasts, 2018-2030
8.5. Asia Pacific
- 8.5.1. Japan
  - 8.5.1.1. Key country dynamics
  - 8.5.1.2. Competitive scenario
  - 8.5.1.3. Regulatory framework
  - 8.5.1.4. Reimbursement scenario
  - 8.5.1.5. Japan market estimates and forecasts, 2018-2030
- 8.5.2. India
  - 8.5.2.1. Key country dynamics
  - 8.5.2.2. Competitive scenario
  - 8.5.2.3. Regulatory framework
  - 8.5.2.4. Reimbursement scenario
  - 8.5.2.5. India market estimates and forecasts, 2018-2030
- 8.5.3. China
  - 8.5.3.1. Key country dynamics
  - 8.5.3.2. Competitive scenario
  - 8.5.3.3. Regulatory framework
  - 8.5.3.4. Reimbursement scenario
  - 8.5.3.5. China market estimates and forecasts, 2018-2030
- 8.5.4. South Korea
  - 8.5.4.1. Key country dynamics
  - 8.5.4.2. Competitive scenario
  - 8.5.4.3. Regulatory framework
  - 8.5.4.4. Reimbursement scenario
  - 8.5.4.5. South Korea market estimates and forecasts, 2018-2030
- 8.5.5. Australia
  - 8.5.5.1. Key country dynamics
  - 8.5.5.2. Competitive scenario
  - 8.5.5.3. Regulatory framework
  - 8.5.5.4. Reimbursement scenario
  - 8.5.5.5. Australia market estimates and forecasts, 2018-2030
- 8.5.6. Thailand
  - 8.5.6.1. Key country dynamics
  - 8.5.6.2. Competitive scenario
  - 8.5.6.3. Regulatory framework
  - 8.5.6.4. Reimbursement scenario
  - 8.5.6.5. Thailand market estimates and forecasts, 2018-2030
8.6. Latin America
- 8.6.1. Brazil
  - 8.6.1.1. Key country dynamics
  - 8.6.1.2. Competitive scenario
  - 8.6.1.3. Regulatory framework
  - 8.6.1.4. Reimbursement scenario
  - 8.6.1.5. Brazil market estimates and forecasts, 2018-2030
- 8.6.2. Argentina
  - 8.6.2.1. Key country dynamics
  - 8.6.2.2. Competitive scenario
  - 8.6.2.3. Regulatory framework
  - 8.6.2.4. Reimbursement scenario
  - 8.6.2.5. Argentina market estimates and forecasts, 2018-2030
8.7. MEA
- 8.7.1. South Africa
  - 8.7.1.1. Key country dynamics
  - 8.7.1.2. Competitive scenario
  - 8.7.1.3. Regulatory framework
  - 8.7.1.4. Reimbursement scenario
  - 8.7.1.5. South Africa market estimates and forecasts, 2018-2030
- 8.7.2. Saudi Arabia
  - 8.7.2.1. Key country dynamics
  - 8.7.2.2. Competitive scenario
  - 8.7.2.3. Regulatory framework
  - 8.7.2.4. Reimbursement scenario
  - 8.7.2.5. Saudi Arabia market estimates and forecasts, 2018-2030
- 8.7.3. UAE
  - 8.7.3.1. Key country dynamics
  - 8.7.3.2. Competitive scenario
  - 8.7.3.3. Regulatory framework
  - 8.7.3.4. Reimbursement scenario
  - 8.7.3.5. UAE market estimates and forecasts, 2018-2030
- 8.7.4. Kuwait
  - 8.7.4.1. Key country dynamics
  - 8.7.4.2. Competitive scenario
  - 8.7.4.3. Regulatory framework
  - 8.7.4.4. Reimbursement scenario
  - 8.7.4.5. Kuwait market estimates and forecasts, 2018-2030

Chapter 9. Competitive Landscape

9.1. Market Participant Categorization
9.2. Key Company Profiles
- 9.2.1. Olympus Corporation
  - 9.2.1.1. Company overview
  - 9.2.1.2. Financial performance
  - 9.2.1.3. Product benchmarking
  - 9.2.1.4. Strategic initiatives
- 9.2.2. Boston Scientific Corporation or its affiliates
  - 9.2.2.1. Company overview
  - 9.2.2.2. Financial performance
  - 9.2.2.3. Product benchmarking
  - 9.2.2.4. Strategic initiatives
- 9.2.3. Ambu Inc.
  - 9.2.3.1. Company overview
  - 9.2.3.2. Financial performance
  - 9.2.3.3. Product benchmarking
  - 9.2.3.4. Strategic initiatives
- 9.2.4. KARL STORZ
  - 9.2.4.1. Company overview
  - 9.2.4.2. Financial performance
  - 9.2.4.3. Product benchmarking
  - 9.2.4.4. Strategic initiatives
- 9.2.5. Advin Health Care
  - 9.2.5.1. Company overview
  - 9.2.5.2. Financial performance
  - 9.2.5.3. Product benchmarking
  - 9.2.5.4. Strategic initiatives
- 9.2.6. Intuitive Surgical (SCHOLLY FIBEROPTIC GMBH)
  - 9.2.6.1. Company overview
  - 9.2.6.2. Financial performance
  - 9.2.6.3. Product benchmarking
  - 9.2.6.4. Strategic initiatives
- 9.2.7. Stryker
  - 9.2.7.1. Company overview
  - 9.2.7.2. Financial performance
  - 9.2.7.3. Product benchmarking
  - 9.2.7.4. Strategic initiatives
- 9.2.8. UroViu Corporation
  - 9.2.8.1. Company overview
  - 9.2.8.2. Financial performance
  - 9.2.8.3. Product benchmarking
  - 9.2.8.4. Strategic initiatives
- 9.2.9. NeoScope Inc.
  - 9.2.9.1. Company overview
  - 9.2.9.2. Financial performance
  - 9.2.9.3. Product benchmarking
  - 9.2.9.4. Strategic initiatives
- 9.2.10. OTU Medical
  - 9.2.10.1. Company overview
  - 9.2.10.2. Financial performance
  - 9.2.10.3. Product benchmarking
  - 9.2.10.4. Strategic initiatives
- 9.2.11. HOYA Corporation (Pentax Medical)
  - 9.2.11.1. Company overview
  - 9.2.11.2. Financial performance
  - 9.2.11.3. Product benchmarking
  - 9.2.11.4. Strategic initiatives
9.3. Heat Map Analysis/ Company Market Position Analysis
9.4. Estimated Company Market Share Analysis, 2024
9.5. List of Other Key Market Players